NCT01893905View on ClinicalTrials.gov

Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

158

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Knee Osteoarthritis
Interventions
DRUG

CS+SG

Chondroitin sulfate+glucosamine sulfate orally administered once a day for 24 weeks.

DRUG

Placebo

Placebo of chondroitin sulfate+glucosamine sulfate orally administered once a day for 24 weeks.

Trial Locations (1)

15006

Complejo Hospitalario Universitario La Coruña, A Coruña

All Listed Sponsors
lead

Tedec-Meiji Farma, S.A.

INDUSTRY

NCT01893905 - Efficacy and Safety of a New Formulation of Chondroitin Sulfate and Glucosamine Sulfate to Treat Knee Osteoarthritis | Biotech Hunter | Biotech Hunter